Lung injury in a variety of disease stales is critically dependent on
neutrophil-mediated inflammatory responses. Neutrophil recruitment to
sites of infection or tissue damage requires coordinated regulation of
neutrophil adhesion and activation status. We have examined the effec
ts of treatment of human peripheral blood neutrophils with priming age
nts [lipopolysaccharide (LPS), tumour necrosis factor-alpha (TNF-alpha
) and platelet-activating factor (PAF)] upon expression of CD11a, CD11
b, CD11c, CD35 and CD62-L and CD11b function to assess whether subtle
regulation of neutrophil adhesion potential accompanies augmented form
yl-methionyl-leucyl-phenylalanine-stimulated superoxide production. We
have found that there are differential effects of 'priming' concentra
tions of these agents. For LPS, CD62L loss occurs in the absence of ch
anges in CD11b, whereas for PAF, CD11b up-regulation occurs in the abs
ence of detectable loss of CD62-L. However, for TNF-alpha, decreased e
xpression of CD62-L occurs concomitantly with increased expression of
CD11b. In addition: we have shown that priming agents augment CD11b fu
nctional activity in a manner that parallels the priming of the respir
atory burst. Thus, priming agents may differentially regulate neutroph
il adhesive capacity and data presented in this manuscript suggest tha
t the increased effector cell function observed in primed cells may be
associated with a distinct repertoire of potential adhesive interacti
ons.